ATE129159T1 - Impfstoff. - Google Patents

Impfstoff.

Info

Publication number
ATE129159T1
ATE129159T1 AT91903336T AT91903336T ATE129159T1 AT E129159 T1 ATE129159 T1 AT E129159T1 AT 91903336 T AT91903336 T AT 91903336T AT 91903336 T AT91903336 T AT 91903336T AT E129159 T1 ATE129159 T1 AT E129159T1
Authority
AT
Austria
Prior art keywords
detoxified
pertussis toxin
vaccine
reversion
toxicity
Prior art date
Application number
AT91903336T
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Application granted granted Critical
Publication of ATE129159T1 publication Critical patent/ATE129159T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT91903336T 1990-02-12 1991-02-07 Impfstoff. ATE129159T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
ATE129159T1 true ATE129159T1 (de) 1995-11-15

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91903336T ATE129159T1 (de) 1990-02-12 1991-02-07 Impfstoff.

Country Status (16)

Country Link
EP (1) EP0515415B1 (de)
JP (1) JP3035712B2 (de)
KR (1) KR100202052B1 (de)
AT (1) ATE129159T1 (de)
AU (1) AU646019B2 (de)
CA (1) CA2075711C (de)
CY (1) CY1935A (de)
DE (1) DE69113991T2 (de)
DK (1) DK0515415T3 (de)
ES (1) ES2080941T3 (de)
GR (1) GR3018440T3 (de)
IE (1) IE70672B1 (de)
NZ (1) NZ237069A (de)
PT (1) PT96723B (de)
WO (1) WO1991012020A1 (de)
ZA (1) ZA91947B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI945483A7 (fi) 1992-05-23 1995-01-20 Smithkline Beecham Biologicals S A Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
JP4601823B2 (ja) * 1998-09-01 2010-12-22 メリオン リサーチ スリー リミテッド 経口ワクチン組成物
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
BR112014017898B1 (pt) 2012-02-01 2021-10-13 Glaxosmithkline Biologicals S.A. Processo de fermentação
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
WO2014024026A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against rsv and b. pertussis
AP2015008702A0 (en) 2013-03-08 2015-09-30 Crucell Holland Bv Acellular pertussis vaccine
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
AU2014304545A1 (en) 2013-08-05 2016-02-25 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
AU5027890A (en) * 1989-02-10 1990-09-05 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
JPH05503936A (ja) 1993-06-24
JP3035712B2 (ja) 2000-04-24
DK0515415T3 (da) 1995-11-27
KR920703099A (ko) 1992-12-17
AU646019B2 (en) 1994-02-03
IE910424A1 (en) 1991-08-14
WO1991012020A1 (en) 1991-08-22
PT96723B (pt) 1998-07-31
CY1935A (en) 1991-02-07
NZ237069A (en) 1993-07-27
HK1004524A1 (en) 1998-11-27
EP0515415B1 (de) 1995-10-18
ES2080941T3 (es) 1996-02-16
DE69113991T2 (de) 1996-03-21
KR100202052B1 (ko) 1999-06-15
ZA91947B (en) 1992-01-29
AU7211091A (en) 1991-09-03
EP0515415A1 (de) 1992-12-02
PT96723A (pt) 1991-10-31
IE70672B1 (en) 1996-12-11
DE69113991D1 (de) 1995-11-23
CA2075711C (en) 2000-11-07
CA2075711A1 (en) 1991-08-13
GR3018440T3 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
DE69022106D1 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
FI913350A7 (fi) Bordetella pertussiksen vastaisia tehokkaita rokotteita, jotka koostuvat erikseen puhdistettujen pertussis-antigeenien yhdistelmästä
DE69113991D1 (de) Impfstoff.
ES2054657T3 (es) Nuevos oligosacaridos y su metodo de preparacion.
FR2522967B1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
LU91155I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutininine filamenteuse, de pertactine, d'agglutinogènes fimbriaux coquelucheux 2 et 3 et de virus poliomyélitique inactivé type 1, type 2 et type 3.
GR870917B (en) Novel mehthod of preparing toxoid
NO872919D0 (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
YU41369B (en) Process for preparing benzofurnace derivatives
ATE183202T1 (de) Pasteurella multocida toxoid enthaltende impfstoffe
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
NO892997L (no) Bordetella pertussis vaksine.
FI884960A0 (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
DE68917972D1 (de) Pertussistoxoid-Impfstoff.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
CA2086258A1 (en) Pasteurella multocida toxoid vaccines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time